Free provider profile
MARISA GEFEN, M.D.
Need more providers like MARISA GEFEN?
See the count and top 3 free, ranked by Medicare billing. Full list $29, included with membership.
Rep intel
What MARISA GEFEN prescribes and who else does
Top Medicare Part D drugs by claims (public CMS data):
- Jardiance
- Ozempic
- Eliquis
- Trelegy Ellipta
- Entresto
See all internal medicine physicians in PA who bill Medicare →
Your next referral list starts here
Provider + market indicator
A combined screening indicator—not a provider fraud-risk score. Local plan ratings describe the surrounding market, not this provider’s quality, plan membership or wrongdoing.
Comparing current CMS billing with peers and checking OIG and plan ratings… A new peer comparison can take about a minute.
Practice contact card
Practice phone
215-444-7470
Fax
215-764-6556
Practice address
37 S 40TH ST, PHILADELPHIA, PA, 19104
- Registry updated
- 2025-04-30
- NPI issued
- 2007-06-05
- RepVector retrieved
- 11/21/2026
A recent retrieval can still contain an old address if the provider has not updated their registry record. Website email checks show their own date under Find email.
Registry record
Source: CMS NPPES registry.
37 S 40TH ST, PHILADELPHIA, PA, 19104
215-444-7470
2 practice locations listed
Enumerated 2007-06-05
- — Registration is active in NPPES.
- — Individual clinician record — reachable, but usually not the buyer.
- — Practice phone number is published.
- — Full street address on file for route planning.
- — 2 practice locations listed — multi-site footprint.
- — Record updated within the last three years.
Medicare Part D prescribing
Source: CMS Medicare Part D Prescribers by Provider, most recent public year.
Part D claims
6,843
Medicare patients
271
Part D drug cost
$821,054
Brand-name share
15.4%
of this prescriber's Part D claims
| Drug | Claims | Medicare cost |
|---|---|---|
| Ozempic (Semaglutide) | 107 | $138,914 |
| Eliquis (Apixaban) | 87 | $100,959 |
| Jardiance (Empagliflozin) | 118 | $91,177 |
| Trelegy Ellipta (Fluticasone/Umeclidin/Vilanter) | 59 | $59,938 |
| Mounjaro (Tirzepatide) | 38 | $52,248 |
| Entresto (Sacubitril/Valsartan) | 40 | $32,061 |
| Anoro Ellipta (Umeclidinium Brm/Vilanterol Tr) | 31 | $29,884 |
| Trulicity (Dulaglutide) | 20 | $28,262 |
Want their full drug mix and peer benchmark? Run the free Part D prescriber lookup.
Latest Medicare Part B billing
CMS Physician and Other Practitioners, by Provider and Service. New published billing years are detected daily, using the same release as the Billing analyst and risk maps.
Loading the latest published CMS billing file…
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
Checking Open Payments…
Industry payments across PA — which companies pay providers there.
Open Payments page for this provider
- Registry data comes straight from CMS NPPES, which lists registration, not activity — a listed practice may have moved or closed.
- Part D covers Medicare prescription drug enrollees only. Commercial, Medicaid and cash-pay prescribing is not included, so these figures are a floor on real volume, not the whole picture.
- CMS publishes the Part D file annually, roughly two years behind the prescribing year. Drugs with 10 or fewer claims are suppressed.
